O
CVS icon

OppenheimerFunds’s CVS Health CVS Stock Holding History

OppenheimerFunds’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$20.8M Buy
385,091
+154,644
+67% +$9.54M 0.03% 529
2018
Q4 		$15.1M Sell
230,447
-1,055
-0.5% -$78.8K 0.02% 577
2018
Q3 		$18.2M Sell
231,502
-21,777
-9% -$1.56M 0.02% 607
2018
Q2 		$16.3M Sell
253,279
-1,185
-0.5% -$78.1K 0.02% 632
2018
Q1 		$15.8M Sell
254,464
-136,212
-35% -$9.77M 0.02% 619
2017
Q4 		$28.3M Sell
390,676
-289,353
-43% -$21M 0.03% 472
2017
Q3 		$55.3M Buy
680,029
+84,604
+14% +$6.69M 0.07% 287
2017
Q2 		$47.9M Sell
595,425
-297,710
-33% -$23.5M 0.06% 307
2017
Q1 		$70.1M Buy
893,135
+100,828
+13% +$8.05M 0.08% 242
2016
Q4 		$62.5M Buy
792,307
+175,152
+28% +$14.2M 0.08% 263
2016
Q3 		$54.9M Sell
617,155
-1,184,562
-66% -$112M 0.07% 293
2016
Q2 		$172M Sell
1,801,717
-119,440
-6% -$11.9M 0.23% 119
2016
Q1 		$199M Sell
1,921,157
-636,937
-25% -$61.9M 0.26% 96
2015
Q4 		$250M Sell
2,558,094
-192,574
-7% -$18.9M 0.32% 82
2015
Q3 		$265M Sell
2,750,668
-96,052
-3% -$10.1M 0.36% 75
2015
Q2 		$299M Sell
2,846,720
-137,930
-5% -$14.1M 0.34% 74
2015
Q1 		$308M Sell
2,984,650
-227,110
-7% -$23M 0.34% 79
2014
Q4 		$309M Sell
3,211,760
-238,340
-7% -$21M 0.34% 84
2014
Q3 		$275M Sell
3,450,100
-639,870
-16% -$50.4M 0.3% 87
2014
Q2 		$308M Buy
4,089,970
+19,120
+0.5% +$1.45M 0.34% 74
2014
Q1 		$305M Buy
4,070,850
+431,910
+12% +$30.5M 0.36% 73
2013
Q4 		$260M Buy
3,638,940
+457,210
+14% +$29.4M 0.32% 80
2013
Q3 		$181M Buy
3,181,730
+808,020
+34% +$48.1M 0.24% 112
2013
Q2 		$136M Buy
+2,373,710
New +$138M 0.2% 137

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OppenheimerFunds's CVS Position: Q1 2019 in Review

OppenheimerFunds increased its CVS Health (CVS) stake by 67% in Q1 2019, buying an estimated $9.54M and bringing the position to 385,091 shares worth $20.8M. The position accounts for 0.03% of the portfolio, ranked #529.

OppenheimerFunds first reported a position in CVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $309M in Q4 2014. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • OppenheimerFunds held 385,091 shares of CVS Health worth $20.8M as of Q1 2019.
  • OppenheimerFunds bought 154,644 CVS Health shares in Q1 2019, an estimated $9.54M.
  • CVS Health made up 0.03% of OppenheimerFunds's portfolio in Q1 2019, its #529 holding.
  • OppenheimerFunds first reported a position in CVS Health in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's CVS Health position peaked at $309M in Q4 2014.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.